Hungry-bone syndrome

01OverviewDefinition, clinical context and the essential points that orientate the chapter.

Longstanding PTH excess accelerates bone turnover. Once the source is removed, osteoblast-driven mineralisation can dominate and draw calcium, phosphate and magnesium from extracellular fluid into previously demineralised bone. The fall may begin in the first postoperative days and persist for weeks or longer, distinguishing hungry bone from a brief operative nadir. It is particularly relevant after surgery for severe primary, secondary or tertiary hyperparathyroidism.

Clinical severity reflects the absolute calcium, speed of decline, magnesium, acid–base state and cardiac or neurological vulnerability. Neuromuscular irritability can progress from paraesthesia and cramps to tetany, bronchospasm, laryngospasm, seizure and arrhythmia. The absence of symptoms does not make a falling postoperative trajectory safe, especially when monitoring or medicine access will become less reliable after discharge.

Calcium replacement must be individualised rather than prescribed as a universal schedule. Calcium salt, active vitamin D choice and dose depend on surgery, renal function, dialysis, phosphate, magnesium, gastrointestinal absorption and local product availability. Renal and endocrine specialists should lead high-dose or prolonged therapy, with the current Society for Endocrinology emergency guidance, SmPC and organisation protocol at the bedside.

Key points

Hungry-bone syndrome is sustained postoperative hypocalcaemia caused by rapid skeletal uptake of calcium, phosphate and magnesium after an abrupt fall in excessive parathyroid hormone drive.
Risk is greatest with severe longstanding hyperparathyroid bone turnover, high alkaline phosphatase, radiological bone disease, very high preoperative PTH, vitamin D deficiency and extensive parathyroid surgery.
The biochemical pattern often combines low calcium, low phosphate and low magnesium with a PTH concentration that is not appropriately absent; postoperative hypoparathyroidism more typically produces low calcium with high phosphate and low or inappropriately normal PTH.
Measure adjusted calcium and PTH before discharge after surgery for primary hyperparathyroidism, as NICE recommends, but use ionised calcium when critical illness or albumin makes correction formulae unreliable.
Correct magnesium and vitamin D status as well as calcium because magnesium depletion impairs PTH secretion and action and can make replacement appear ineffective.
Severe symptomatic hypocalcaemia requires monitored intravenous calcium; ongoing hungry-bone losses usually need substantial, individually titrated oral calcium plus an active vitamin D analogue under specialist direction.
Requirements can change rapidly as skeletal remineralisation slows, so an unchanged high replacement regimen can later cause hypercalcaemia or hypercalciuria.
Discharge only with a written dose plan, early blood-test dates, symptom safety-netting and a named endocrine or surgical contact able to adjust treatment promptly.

02AetiologyUnderlying causes, associations and risk factors, with why each one matters.

Severe primary hyperparathyroidism

Longstanding autonomous PTH excess creates high bone turnover before parathyroid surgery abruptly removes the resorptive stimulus.

Renal secondary or tertiary hyperparathyroidism

Marked skeletal turnover in advanced kidney disease can lead to prolonged mineral uptake after removal of enlarged or autonomous parathyroid tissue.

03PathophysiologyThe causal sequence from the underlying abnormality to symptoms and harm.

1
Bone turnover is accelerated
Chronic PTH excess increases osteoclastic resorption and leaves a mineralisation deficit within actively remodelled skeletal tissue.
2
PTH falls after surgery
Removing the hormone source abruptly reduces resorption while osteoblast-driven repair and mineral deposition continue, reversing net mineral flux towards bone.
3
Minerals move into bone
Calcium, phosphate and magnesium shift from extracellular fluid into previously demineralised bone, causing a prolonged postoperative biochemical fall.
4
Neuromuscular excitability rises
Falling ionised calcium destabilises neuronal and muscle membranes, with severity influenced by magnesium, acid-base state and rate of decline.

04Clinical features and red flagsSymptoms, examination findings, patterns of presentation and time-critical warnings.

Early sensory symptomsRed flag

Perioral or fingertip tingling, muscle aching, cramps and heightened reflexes may precede overt tetany and should trigger an immediate calcium check after surgery.

Severe neuromuscular irritabilityRed flag

Carpopedal spasm, stridor, bronchospasm, laryngospasm, confusion or seizure indicates dangerous hypocalcaemia and requires monitored emergency treatment rather than oral replacement alone.

Cardiac toxicityRed flag

QT prolongation, hypotension, heart failure or ventricular arrhythmia can occur, with additional risk from digoxin exposure and coexisting potassium or magnesium disturbance.

High-turnover background

Bone pain, fractures, brown tumours, osteitis fibrosa, very high alkaline phosphatase or severe renal hyperparathyroidism before surgery makes postoperative skeletal mineral demand more likely.

Hungry-bone biochemistry

Persistent falling calcium with low phosphate, low magnesium and evidence of previous high bone turnover supports mineral sequestration when PTH is not frankly absent.

05InvestigationsWhat to request, why it matters and how to interpret it.

Investigation order

Read from the initial assessment onwards. Tests may run in parallel in urgent care; first-line, preferred, confirmatory, definitive and gold-standard labels appear only when the chapter explicitly states them.

01
Serial albumin-adjusted and ionised calciumFirst step
Why
Confirm severity and define the postoperative direction and response to replacement.
Interpretation and limitations
Use the same laboratory method for trends; prioritise ionised calcium in critical illness, major albumin disturbance or acid–base change, where a correction equation may misrepresent biologically active calcium.
02
Parathyroid hormone
Why
Help distinguish skeletal uptake from inadequate postoperative parathyroid function.
Interpretation and limitations
Interpret against simultaneous calcium, timing and renal disease: a measurable or raised value can coexist with hungry bone, whereas an inappropriately low result supports gland failure.
03
Phosphate and magnesium
Why
Identify the associated mineral deficits and refine the differential diagnosis.
Interpretation and limitations
Low phosphate and magnesium are common with rapid bone uptake; high phosphate points towards hypoparathyroidism or renal retention, and magnesium depletion can cause functional PTH resistance.
04
Alkaline phosphatase, vitamin D and renal profile
Why
Estimate antecedent bone turnover and identify contributors to severity and replacement safety.
Interpretation and limitations
A high alkaline phosphatase supports active remineralisation; vitamin D deficiency and impaired kidney function alter calcium absorption, active vitamin D handling and the risk from phosphate or magnesium treatment.
05
Twelve-lead ECG and cardiac monitoring
Why
Detect electrical instability from severe hypocalcaemia and interacting electrolyte abnormalities.
Interpretation and limitations
A prolonged QT or ventricular ectopy increases urgency, but a normal ECG cannot make a substantially low or rapidly falling calcium safe for outpatient care.
06
Operative record and preoperative results
Why
Clarify the amount of tissue removed and the pre-existing turnover burden.
Interpretation and limitations
Review PTH, calcium, phosphate, alkaline phosphatase, vitamin D, imaging and surgical findings; multigland or renal surgery changes both expected course and follow-up ownership.

06Differential diagnosisRealistic alternatives and the features that help distinguish them.

Postoperative hypoparathyroidism

A low or absent PTH after neck surgery suggests gland injury, whereas hungry bone may retain an appropriate PTH response despite prolonged mineral consumption.

Vitamin D deficiency

Low vitamin D impairs mineral absorption and can worsen postoperative hypocalcaemia, but does not alone explain the characteristic high-turnover surgical context.

Hypomagnesaemia

Magnesium deficiency impairs PTH release and action, making calcium difficult to correct until magnesium is restored.

Brief postoperative calcium nadir

A transient early fall that resolves promptly is less consistent with the sustained, high-replacement course of hungry bone syndrome.

Additional chapter-specific clues

Alternative gland failure

Low or inappropriately normal postoperative PTH with a rising phosphate concentration favours hypoparathyroidism, although both processes can overlap and require specialist interpretation.

07ManagementImmediate care, first-line treatment, alternatives and escalation.

01AnticipatePrepare before high-risk surgeryFirst stepA patient with marked primary or renal hyperparathyroidism is scheduled for parathyroid surgery.

1Identify high bone-turnover features, renal impairment, vitamin D and magnesium deficiency, previous fractures and medicines that complicate calcium interpretation or replacement.
2Agree the postoperative calcium, phosphate, magnesium and PTH schedule with endocrine, renal and surgical teams, including the monitored setting and access to intravenous calcium.
3Give the patient specific symptom education and establish a specialist-led oral calcium and vitamin D plan rather than leaving supplementation to an unreviewed routine prescription.

02DifferentiateExplain the postoperative fallCalcium declines or replacement need persists after parathyroidectomy.

1Assess symptoms, ECG and ionised or adjusted calcium first, treating severe features immediately while drawing paired PTH, phosphate, magnesium and renal tests.
2Compare the pattern with preoperative turnover and operative findings, considering hungry bone, hypoparathyroidism, vitamin D deficiency, pancreatitis, sepsis, transfusion citrate and medicine effects.
3Trend rather than label from one sample, because skeletal uptake and impaired gland function can coexist and their relative contributions change during recovery.

03ReplaceRestore calcium and companion mineralsBiochemistry and clinical context support hungry-bone syndrome with ongoing mineral requirement.

1For seizure, tetany, laryngospasm, arrhythmia or other severe manifestation, give monitored intravenous calcium gluconate through the current emergency chart and repeat testing promptly.
2Once stable and able to absorb treatment, use specialist-titrated oral calcium plus an active vitamin D analogue, correcting magnesium and reviewing phosphate without creating calcium–phosphate precipitation risk.
3Adjust against frequent calcium, phosphate, magnesium, creatinine, symptoms and urine risk where indicated, recognising that dialysis patients need a renal-unit-specific mineral prescription.

04DischargeTaper safely as bone demand resolvesCalcium is clinically stable on an oral regimen and the patient can manage treatment outside hospital.

1Supply an exact written regimen, interaction and timing advice, missed-dose instructions, emergency symptoms and scheduled early laboratory checks with named result ownership.
2Reduce replacement only from serial results and specialist advice; monitor for constipation, renal stones, hypercalcaemia, hypercalciuria and an abrupt fall in requirement.
3Complete NICE postoperative calcium and PTH follow-up while adapting the frequency for ongoing hungry bone, renal disease or evidence of recurrent hyperparathyroidism.

Key medicines and prescribing safety2 treatments · regimens, roles and cautions

Provides immediate extracellular calcium during tetany, seizure, airway compromise or cardiac electrical instability while sustained replacement is arranged.

Calcium gluconate 10% for acute symptoms

For acute symptomatic hypocalcaemia, the current SmPC permits 10–20 mL by slow intravenous injection or diluted infusion over 10 minutes with plasma calcium and ECG monitoring; repeat and continuing infusion decisions require the live protocol and senior review.

Confirm the product because calcium gluconate and calcium chloride are not equivalent. Ensure venous patency, avoid extravasation, monitor rhythm, consider digoxin toxicity and renal impairment, and do not use a short bolus as the complete treatment for ongoing skeletal uptake.

Maintains intestinal calcium supply and absorption throughout the prolonged remineralisation phase after emergency stability is achieved.

Oral calcium with active vitamin D

Dose and divide the locally selected calcium preparation and calcitriol or alfacalcidol individually under endocrine or renal supervision, titrating to serial biochemistry rather than applying a fixed universal hungry-bone regimen.

Check elemental calcium content, renal function, phosphate, magnesium, vitamin D, interactions and adherence. High requirements may fall suddenly; continued unchanged dosing can cause hypercalcaemia, hypercalciuria, nephrocalcinosis or calcium–phosphate deposition.

08ComplicationsImportant consequences, why they occur and why they matter clinically.

Tetany and seizure

Progressive hypocalcaemia causes paraesthesia, cramps and carpopedal spasm, potentially advancing to laryngospasm, bronchospasm or seizure as ionised calcium continues to fall.

Cardiac electrical instability

Low calcium and associated magnesium disturbance prolong repolarisation and can trigger clinically important arrhythmia, especially when the biochemical fall is rapid.

Prolonged replacement dependence

Mineral uptake may continue for weeks or longer, creating readmission risk if monitoring, active vitamin D or calcium access is unreliable.

09Monitoring and follow-upTreatment response, safety checks and longer-term review.

Measure calcium at the frequency set by severity and trajectory, commonly several times daily during active intravenous replacement and less often only after a reproducible plateau.
Trend phosphate, magnesium, potassium and creatinine alongside calcium because each changes replacement safety and can explain an apparently inadequate clinical response.
Use continuous rhythm monitoring during severe symptoms or intravenous calcium, repeating ECG assessment when QT prolongation or ectopy was present initially.
Record all oral and intravenous elemental calcium, active vitamin D and magnesium administered so falling biochemical need is not obscured by undocumented dose changes.
After discharge, arrange early results with same-day dose ownership, then extend intervals only as calcium and replacement requirements stabilise.
Reassess PTH and the underlying hyperparathyroid disease at the surgical or renal follow-up, separating transient hungry bone from persistent gland dysfunction or recurrent disease.

10Special situationsVariants, exceptions and circumstances that change the usual approach.

Phosphate helps separate mechanisms

Skeletal remineralisation tends to lower phosphate, whereas absent PTH reduces renal phosphate excretion; the simultaneous pattern is more informative than calcium alone.

Magnesium can block recovery

Severe magnesium depletion both reduces PTH secretion and impairs its peripheral effect, so escalating calcium without magnesium review may fail.

Turnover predicts duration

A markedly raised preoperative alkaline phosphatase signals a large mineralisation sink and should prompt a more intensive monitoring and discharge plan.

Ionised calcium changes with pH

Alkalosis increases calcium binding to albumin and can intensify symptoms even when total calcium appears less alarming, supporting direct ionised measurement.

Renal disease changes everything

Dialysis, phosphate retention and altered vitamin D activation make standard postoperative supplementation unreliable; renal-unit ownership is essential.

Recovery creates a new hazard

When bone uptake slows, yesterday’s necessary high-dose regimen may become excessive, so planned tapering is part of treatment rather than an afterthought.

11Common pitfallsFrequent interpretation and management errors.

01
Calling every low calcium after parathyroid surgery hypoparathyroidism without using the PTH, phosphate, magnesium and turnover pattern.
02
Waiting for corrected calcium from the main laboratory while a patient with stridor, tetany or seizure has clinically severe hypocalcaemia.
03
Escalating calcium repeatedly but overlooking magnesium depletion, poor absorption, omitted active vitamin D or an infiltrated intravenous line.
04
Using a calcium chloride dose as though it were directly interchangeable with the same volume of calcium gluconate.
05
Discharging on a complex high-dose regimen without an early blood-test appointment, named reviewer or guidance for neurological and airway symptoms.
06
Failing to reduce replacement when remineralisation slows, leading to avoidable hypercalcaemia, renal injury or soft-tissue calcification.